media – Page 734 – Pharma & Medical Industry Insights Hub | Drugdu Insights & Updates

UNAIDS announces nearly 21 million people living with HIV now on treatment

Remarkable progress is being made on HIV treatment. Ahead of World AIDS Day, UNAIDS has launched a new report showing that access to treatment has risen significantly. In 2000, just 685 000 people living with HIV had access to antiretroviral therapy. By June 2017, around 20.9 million people had access to the life-saving medicines. Such a dramatic scale-up could not have happened without the courage and determination of people living with HIV demanding and claiming their rights, backed up by steady, strong leadership and financial commitment.
- Source: reliefweb
- 535
- November 21, 2017
antiretroviral HIV UNAIDS
Ddu attended MEDICA in Germany

MEDICA is the main attraction for all those involved in the health care industry. With its numerous special events, international conferences and forum programs, not to mention the largest and most comprehensive product display in the industry, MEDICA is the hub for international medical trade.
- Source: Ddu
- 1,352
- November 21, 2017
Exhibitions & Activities MEDICA RFQ
Maintaining sufficient vitamin D levels may help to prevent rheumatoid arthritis

Maintaining sufficient vitamin D levels may help to prevent the onset of inflammatory diseases like rheumatoid arthritis, research led by the University of Birmingham has discovered.
- Source: medicalxpress
- 748
- November 21, 2017
inflammatory diseases rheumatoid arthritis vitamin D
Bird Flu Is Spreading in Asia, Experts (Quietly) Warn

Since October 2016, China has seen a “fifth wave” of H7N9 infections. Nearly 1,600 people have tested positive, almost 40 percent of whom have died.
- Source: Postnewsreport
- 678
- November 21, 2017
bird flu China H7N9 Researches
High-tech neuroprosthetic ‘Luke’ arm lets amputee touch and feel again

Walgamott was describing the results of an experimental surgery to The Washington Post, where a prosthetic known as the “Luke” arm had been attached with electrodes implanted into his nerves. The real estate agent had lost his hand and most of his arm in an electrical accident 14 years ago, and he volunteered for the program at the University of Utah.
- Source: digitaltrends
- 544
- November 20, 2017
Market Views neuroprosthetic prosthetic
This Artificial Kidney Eliminates The Need For Kidney Dialysis

It is estimated by The National Kidney Foundation that over 100,000 patients are on the waiting list for kidney donors. A further 3,000 names are added to the list every year. An average patient has to wait for 3.6 years for a viable transplant. The patients are treated with dialysis while they are waiting for a transplant and only one in three patients survive for more than five years without a transplant. All that could change as scientists have developed the world’s first artificial kidney.
- Source: wonderfulengineering
- 731
- November 20, 2017
artificial kidney Market Views
Psychedelics and Psychotherapy–Is There a Role for MDMA in the Treatment of PTSD?

In a recent study, scientists investigate the use of MDMA in conjunction with psychotherapy as an aid in treating and alleviating PTSD symptoms.
- Source: medicalnewsbulletin
- 707
- November 20, 2017
psychotherapy PTSD symptom Researches
Cue Biopharma Announces Strategic Research Collaboration and License Agreement with Merck

Biopharma™, Inc., an immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat cancer and autoimmune diseases, announced a strategic research collaboration and license agreement with Merck, known as MSD outside of the United States and Canada.
- Source: biotech-365
- 646
- November 20, 2017
autoimmune immunotherapy Market Views
FDA approves new treatment Hemlibra (emicizumab-kxwh) to prevent bleeding in certain patients with hemophilia A

The U.S. Food and Drug Administration(FDA) approved Hemlibra (emicizumab-kxwh) to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A who have developed antibodies called Factor VIII (FVIII) inhibitors.
- Source: pharmacist
- 954
- November 20, 2017
FDA Hemlibra hemophilia inhibitor New Approvals
Pfizer Receives FDA Approval for SUTENT® (sunitinib malate) as First and Only Adjuvant Treatment for Adult Patients

Pfizer Inc. (PFE) announced that the U.S. Food and Drug Administration(FDA) has approved a new indication expanding the use of SUTENT® (sunitinib malate) to include the adjuvant treatment of adult patients at high risk of recurrent renal cell carcinoma (RCC) following nephrectomy (surgical removal of the cancerous kidney). The approval was based on results from the S-TRAC trial that demonstrated a significant reduction in the risk of a disease-free survival (DFS) event (defined as the interval between randomization and tumor recurrence, or secondary primary cancer or death from any cause) for patients at high risk of RCC recurrence who received SUTENT compared to placebo in the adjuvant setting.
- Source: finance.yahoo
- 612
- November 20, 2017
DFS FDA nephrectomy RCC SUTENT

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.